- Home
- UTMD vs GOSS Comparison
UTMD vs GOSS Comparison
Compare UTMD & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTMD
- GOSS
- Stock Information
- Founded
- UTMD 1978
- GOSS 2015
- Country
- UTMD United States
- GOSS United States
- Employees
- UTMD N/A
- GOSS N/A
- Industry
- UTMD Medical/Dental Instruments
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- UTMD Health Care
- GOSS Health Care
- Exchange
- UTMD Nasdaq
- GOSS Nasdaq
- Market Cap
- UTMD 171.3M
- GOSS 203.3M
- IPO Year
- UTMD N/A
- GOSS 2019
- Fundamental
- Price
- UTMD $53.60
- GOSS $1.11
- Analyst Decision
- UTMD
- GOSS Strong Buy
- Analyst Count
- UTMD 0
- GOSS 4
- Target Price
- UTMD N/A
- GOSS $7.50
- AVG Volume (30 Days)
- UTMD 15.6K
- GOSS 1.5M
- Earning Date
- UTMD 04-29-2025
- GOSS 05-20-2025
- Dividend Yield
- UTMD 2.27%
- GOSS N/A
- EPS Growth
- UTMD N/A
- GOSS N/A
- EPS
- UTMD 3.78
- GOSS N/A
- Revenue
- UTMD $39,273,000.00
- GOSS $114,701,000.00
- Revenue This Year
- UTMD N/A
- GOSS N/A
- Revenue Next Year
- UTMD N/A
- GOSS $172.31
- P/E Ratio
- UTMD $14.24
- GOSS N/A
- Revenue Growth
- UTMD N/A
- GOSS N/A
- 52 Week Low
- UTMD $51.26
- GOSS $0.50
- 52 Week High
- UTMD $77.33
- GOSS $1.55
- Technical
- Relative Strength Index (RSI)
- UTMD 48.81
- GOSS 55.81
- Support Level
- UTMD $51.80
- GOSS $1.06
- Resistance Level
- UTMD $54.78
- GOSS $1.26
- Average True Range (ATR)
- UTMD 1.22
- GOSS 0.11
- MACD
- UTMD 0.35
- GOSS 0.03
- Stochastic Oscillator
- UTMD 66.48
- GOSS 67.95
About UTMD Utah Medical Products Inc.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.